News in brief

January 2004
PharmacoEconomics & Outcomes News;1/17/2004, Issue 444, p6
Discusses research being done on the use of beta-blocker in patients with chronic heart failure. Reference to a study by R. Gupta et al, published in the January 2004 issue of the "American Heart Journal"; Percentage of the patients who were receiving beta-blocker; Age range of the patients.


Related Articles

  • Carvedilol superior to metoprolol for preventing death from CHF. Damitz, Beth A.; Lord, Richard W.; Muerer, Linda N. // Journal of Family Practice;Nov2003, Vol. 52 Issue 11, p830 

    A study of 3029 patients with symptomatic mild to severe chronic heart failure (CHF) from 341 centers in European countries showed that carvedilol is more effective than metropolol in preventing death from CHF. The patients were predominantly male and Caucasian. Most of them had class II or...

  • TOLERABILITY OF BETA-BLOCKERS IN OLDER PEOPLE WITH CHRONIC HEART FAILURE IN CLINICAL PRACTICE. Tan, M. P.; Spensley, A.; Oliver, J.; Majmudar, N.; Baxter, J. // Age & Ageing;Jul2005 Supplement1, Vol. 34, pi10 

    Discusses research being done on tolerability of beta-blockers in older people with chronic heart failure. Reference to a study by M. P. Tan and colleagues, presented at the autumn meeting of the British Geriatrics Societies in October 2004; Percentage of the study population in which...

  • Effect of Beta-blockade and ACE Inhibition on B-type Natriuretic Peptides in Stable Patients with Systolic Heart Failure. Jens Rosenberg; Finn Gustafsson; Willem Remme; Günter Riegger; Per Hildebrandt // Cardiovascular Drugs & Therapy;Aug2008, Vol. 22 Issue 4, p305 

    Abstract Introduction  The long-term effect of beta-blockade on the plasma levels of natriuretic peptides BNP and its N-terminal counterpart, NT-proBNP, as risk markers in heart failure (HF) is obscure. Methods  Stable systolic HF patients from the CARMEN study...

  • Which Beta-Blocker is Most Effective in Heart Failure? Remme, Willem J. // Cardiovascular Drugs & Therapy;Aug2010, Vol. 24 Issue 4, p351 

    The article discusses several beta-blocker which effectively treat the chronic hearth failure in Netherlands. It explains that beta-blockade mainly accepted as mandatory therapy in patients with stable, mild, moderate and severe heart failure (HF). In this regard, several studies for...

  • Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological study. Maison, Patrick; Cunin, Patrick; Hemery, François; Fric, Florence; Elie, Nicole; Del'Volgo, Aldo; Dubois-Randé, Jean; Hittinger, Luc; Macquin-Mavier, Isabelle // European Journal of Clinical Pharmacology;Jul2005, Vol. 61 Issue 5/6, p445 

    Objectives: Trials in chronic heart failure (CHF) include few patients older than 75 years, who represent a large proportion of CHF patients. We evaluated the influence of age on CHF-medication use and of CHF medications on hospitalisation in patients older than 75 years. Methods: Included in...

  • Carvedilol or Metoprolol for Chronic Heart Failure? Walling, Anne D. // American Family Physician;2/15/2004, Vol. 69 Issue 4, p985 

    Discusses research being done on the efficacy of carvedilol and metoprolol in the treatment of patients with mild to severe chronic heart failure. Reference to a study by P.A. Poole-Wilson et al published in the July 5, 2003 issue of the journal "Lancet"; Comparison between the baseline...

  • Beta-blockers in heart failure. Newson, Louise // GP: General Practitioner;2/2/2007, p45 

    The article focuses on the use of beta-blockers in heart failure (HF). The author thinks that HF is a common but poorly managed condition. In the Cardiac Insufficiency Bisoprolol Trial II, the Carvedilol Prospective Randomised Cumulative Survival Study (COPERNICUS) and the Metoprolol Randomised...

  • Medicine in the News. Saunders, Carol S. // Patient Care for the Nurse Practitioner;Aug2001, Vol. 4 Issue 8, p8 

    Evaluates the ability of the beta blocker carvedilol to reduce the risk of hospitalization and death of patients with severe heart disease. Decrease in the death and hospitalization risk with carvedilol treatment; Beta-blockers that have been proven to be effective in treating heart failure;...

  • Putting a block on heart failure deaths. Ahmed, Mohammed // GP: General Practitioner;6/3/2002, p70 

    Focuses on the benefits of beta-blockers in treating heart failure. Improvement of left ventricular functions; Performance of clinical trials on the effects of carvedilol; Reduction of mortality.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics